Financial Highlights

Financial Highlights


Annual Financial Highlights

Year Ended Dec. 31, 2011 Year Ended Dec. 31, 2012 Year Ended Dec. 31, 2013 Year Ended Dec. 31, 2014 Year Ended Dec. 31, 2015 Nine Months Ended - September 30, 2016
Revenues (000) $169,316 $178,113 $197,979 $262,810 $282,293 $201,518
Gross Profit (000) 77,214 85,217 80,105 133,797 149,742 104,248
Operating Income (Loss) (000) 11,771 12,240 (28,656) 5,625 24,625 (2,047)
Basic Net Income (Loss) Per Share 0.15 0.15 (0.34) (0.01) 0.20 (0.10)
Diluted Net Income (Loss) Per Share 0.15 0.15 (0.34) (0.01) 0.20 (0.10)
Current Assets (000) 159,681 166,572 186,659 197,496 191,714 182,823
Total Assets (000) 230,027 241,409 369,854 378,135 381,065 374,410
Total Stockholders’ Equity (000) $172,419 $183,992 $168,053 $167,835 $181,356 $178,339

Results by Revenue Category

Year Ended Dec. 31, 2013 Year Ended Dec. 31, 2014 Year Ended Dec. 31, 2015 Nine Months Ended - September 30, 2016
Spine $17,929 $52,270 $57,983 $52,514
Sports / Ortho $44,907 $48,975 $50,712 $36,956
Surgical Specialties $402 $1,631 $3,029 $2,985
Cardiothoracic $2,616 $6,997 $8,699 $8,332
International $17,215 $20,327 $18,338 $15,532
Total Direct $83,069 $130,200 $138,761 $116,319
Global Commercial $106,693 $120,910 $129,930 $75,396
Other $8,217 $11,700 $13,602 $9,803
Total Revenue $197,979 $262,810 $282,293 $201,518
Domestic $177,207 $238.936 $260,387 $183,192
International $20,772 $23,874 $21,906 $18,326
Total Revenue $197,979 $262,810 $282,293 $201,518

Current Revenue Reporting Format

($ in thousands)

Historical Revenue Reporting Format

($ in thousands)